Literature DB >> 1773823

The physical dependence liability of butorphanol: a comparative study with morphine.

P Horan1, I K Ho.   

Abstract

In these studies, the physical dependence liability of butorphanol, a mixed 'agonist/antagonist' opioid analgesic, was compared to that of morphine. Male, Sprague-Dawley rats received i.c.v. infusions of saline (1 microliter/h), or an equimolar dose of butorphanol or morphine (52.3 nmol/h) for 3 days. The physical dependence liabilities of these two compounds were then compared by assessing both behavioral withdrawal signs and weight loss following naloxone-precipitated withdrawal. Body weight loss was also evaluated following abrupt (cessation of infusion) withdrawal from butorphanol or morphine. In animals receiving i.c.v. infusions of butorphanol or morphine, naloxone administration (5 mg/kg s.c.) induced an equivalent degree of body weight loss compared to saline-treated animals. In addition, the ED50 of naloxone to produce wet shakes, escape behavior, teeth chattering, urination and defecation was equivalent in rats receiving butorphanol or morphine. Infusions of butorphanol or morphine also produced an equivalent degree of weight loss in animals undergoing abrupt withdrawal. These results demonstrate then that a substantial degree of physical dependence had developed in rats which received a large dose of butorphanol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1773823     DOI: 10.1016/0014-2999(91)90895-w

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Modulation of NMDA receptor subunit mRNA in butorphanol-tolerant and -withdrawing rats.

Authors:  S Oh; J I Kim; M W Chung; I K Ho
Journal:  Neurochem Res       Date:  2000-12       Impact factor: 3.996

2.  Simultaneous measurement of biogenic amines and their metabolites in rat brain regions after acute administration of and abrupt withdrawal from butorphanol or morphine.

Authors:  H Wakabayashi; S Tokuyama; I K Ho
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

3.  Discharge activities of neurons in the nucleus paragigantocellularis during the development of morphine tolerance and dependence: a single unit study in chronically implanted rats.

Authors:  Hong Zhu; Wu Zhou
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

4.  Effects of morphine, naloxone, buprenorphine, butorphanol, haloperidol and imipramine on morphine withdrawal signs in cynomolgus monkeys.

Authors:  H Fukase; K Fukuzaki; T Koja; R Nagata; S E Lukas
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

5.  Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence.

Authors:  Y Z Feng; T Zhang; S Tokuyama; H Zhu; R W Rockhold; I K Ho
Journal:  Neurochem Res       Date:  1996-01       Impact factor: 3.996

6.  The bindings of [3H]muscimol and [3H]flunitrazapam are elevated in discrete brain regions of butorphanol-withdrawal rats.

Authors:  So Yong Jang; Younghwa Kim; Seikwan Oh
Journal:  Neurochem Res       Date:  2002-09       Impact factor: 3.996

7.  Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat.

Authors:  Y Z Feng; T Zhang; R W Rockhold; I K Ho
Journal:  Neurochem Res       Date:  1995-06       Impact factor: 3.996

8.  Changes of the level of G protein alpha-subunit mRNA by tolerance to and withdrawal from butorphanol.

Authors:  Dong Sup Kim; Hwa Kyung Lim; Soyong Jang; Seikwan Oh
Journal:  Neurochem Res       Date:  2003-12       Impact factor: 3.996

9.  Physiological dependence to mitragynine indicated by a rapid cross-dependence procedure with heroin-dependent mice.

Authors:  Kai Yue; Jonathan L Katz; Xiji Shu
Journal:  Psychopharmacology (Berl)       Date:  2022-02-02       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.